Manhattan Pharmaceuticals Overview

  • Year Founded
  • 1993

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 2

  • Investments
  • 2

Manhattan Pharmaceuticals General Information

Description

Operator of a specialty healthcare products company focused on the development and commercialization of innovative treatments for underserved patient populations. The company develops monoclonal antibodies drugs bioengineered to enhance the biological treatment of various proliferative disorders including lymphoma, leukemia, and auto-immune diseases.

Contact Information

Formerly Known As
Manhattan Research Development
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 48 Wall Street
  • Suite 1100
  • New York, NY 10015
  • United States
Primary Industry
Pharmaceuticals
Other Industries
Other Pharmaceuticals and Biotechnology
Other Consumer Non-Durables
Acquirer
Corporate Office
  • 48 Wall Street
  • Suite 1100
  • New York, NY 10015
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Manhattan Pharmaceuticals Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Manhattan Pharmaceuticals‘s full profile, request access.

Request a free trial

Manhattan Pharmaceuticals Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Manhattan Pharmaceuticals‘s full profile, request access.

Request a free trial

Manhattan Pharmaceuticals Acquisitions (2)

Manhattan Pharmaceuticals’s most recent deal was a Reverse Merger with TG Therapeutics. The deal was made on 12-Mar-2010.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
TG Therapeutics 12-Mar-2010 Reverse Merger Pharmaceuticals
Tarpan Therapeutics 01-Apr-2005 Merger/Acquisition Pharmaceuticals
To view Manhattan Pharmaceuticals’s complete acquisitions history, request access »

Manhattan Pharmaceuticals Exits (1)

Manhattan Pharmaceuticals’s most recent exit was on 12-Mar-2010 from TG Therapeutics. The exit was categorized as .

Company Name Exit Date Exit Type Exit Size Status Buyers
TG Therapeutics 12-Mar-2010 Completed
To view Manhattan Pharmaceuticals’s complete exits history, request access »

Manhattan Pharmaceuticals FAQs

  • When was Manhattan Pharmaceuticals founded?

    Manhattan Pharmaceuticals was founded in 1993.

  • Where is Manhattan Pharmaceuticals headquartered?

    Manhattan Pharmaceuticals is headquartered in New York, NY.

  • What industry is Manhattan Pharmaceuticals in?

    Manhattan Pharmaceuticals’s primary industry is Pharmaceuticals.

  • Is Manhattan Pharmaceuticals a private or public company?

    Manhattan Pharmaceuticals is a Private company.

  • What is Manhattan Pharmaceuticals’s current revenue?

    The current revenue for Manhattan Pharmaceuticals is .

  • Who are Manhattan Pharmaceuticals’s investors?

    Atlantic Technology Ventures has invested in Manhattan Pharmaceuticals.

  • When was Manhattan Pharmaceuticals acquired?

    Manhattan Pharmaceuticals was acquired on 12-Mar-2010.

  • Who acquired Manhattan Pharmaceuticals?

    Manhattan Pharmaceuticals was acquired by TG Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process